TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from COSCIENS Biopharma ( (TSE:CSCI) ).
COSCIENS Biopharma Inc. reported a significant reduction in operating expenses by 59% in Q3 2025 compared to Q3 2024, following a restructuring and zero-based budgeting initiative. The company voluntarily delisted from Nasdaq, maintaining its TSX listing, and applied for trading on the OTCQB® Venture Market, as part of a strategic move to reduce costs and enhance competitiveness.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. is a life science company focused on natural ingredients and pharmaceutical solutions. The company operates in markets such as cosmeceutical, personal care, veterinary health, and is exploring opportunities in food and beverage, dermatology, and pharmaceutical markets.
Average Trading Volume: 3,716
Technical Sentiment Signal: Sell
Current Market Cap: C$10.87M
For an in-depth examination of CSCI stock, go to TipRanks’ Overview page.